ACE2 and myocardial infarction: The development and deterioration of pathophysiological processes such inflammation, fibrosis, and oxidative stress in myocardial infarction, hypertension, and hypertrophic cardiomyopathy have been demonstrated to be inhibited by ACE2 [22–24].